Several studies showed that the serum and/or plasma levels of BNP and NT-proBNP are increased in patients with cardioembolic stroke [22,23,24], suggesting that they may have potential as possible biomarkers for stroke of CE etiology. The gene discussed is NPPB; the disease is cholesteryl ester measurement.